期刊文献+

乳腺癌组织芯片中BAG-1和p73及p16的表达及其意义 被引量:4

Expressions and significance of BAG-1,p73 and p16 in breast cancer tissue microarray
下载PDF
导出
摘要 目的:检测BAG-1、p73和p16在乳腺癌、癌旁组织和正常组织中的表达,并讨论其意义。方法:利用组织芯片采用免疫组化DAKO Envision法检测乳腺癌、癌旁组织、正常组织中BAG-1、p73和p16的表达。结果:组织芯片中BAG-1、p73和p16在胞核、胞质均有表达,在正常组织中以胞质为主,但随着病变表达逐渐增加。在乳腺癌组织中的表达比乳腺癌癌旁组织、正常组织中高,差异有统计学意义,P<0·01;而p16的表达正好相反,差异亦有统计学意义,P<0·01。BAG-1、p73和p16的阳性率在Ⅰ级和Ⅱ、Ⅲ级乳腺癌之间差异无统计学意义,P>0·05。结论:BAG-1、p73和p16表达的变化提示它们可能参与了乳腺癌的发生。 OBJECTIVE:To detect BAG-1, p73, p16 expressions in breast cancer by tissue microarray and evaluate their clinical significance. METHODS: Tissue mieroarray of breast cancer, atypoical hyperplasia and normal tissues were analyzed by DAKO Envision system immunohistochemical staining for BAG-1, p73 and p16 expressions. RESULTS: BAG-1, p73 and p16 were expressed in nucleus and cytoplasm in cancer tissue, they were mainly existed in cytoplasm in normal epithelium. With the change procedure from the normal cell to dysplasia to cancer tissue, the degrees of BAG-1 and p73 increased gradually, while the degree of p16 decreased. There were significant differences of positive rates of BAG-1, p73 and p16 between the cancer tissue and the normal,P〈0. 01. but there were no significant differences of positive rates of BAG-1, p73 and p16 between the gradeⅠand gradeⅡ, Ⅲcancer tissues, P〉0. 05. CONCLUSION: There are overexpressions of BAG-1, p73 and p16 in breast cancer. It suggests that BAG-1, p73 and p16 may be related to breast cancer.
出处 《中华肿瘤防治杂志》 CAS 2006年第3期196-198,共3页 Chinese Journal of Cancer Prevention and Treatment
关键词 乳腺肿瘤 组织芯片 癌基因 免疫组织化学 breast neoplasms tissue microarray oncogenes immunohistochemistry
  • 相关文献

参考文献10

  • 1司少艳,张建中,韩瑞刚,郑燕华.利用组织芯片技术观察p53及其同系物p63在恶性肿瘤中的表达[J].中国临床康复,2003,7(17):2426-2427. 被引量:16
  • 2Liu SS,Leung R C,Chan K Y,et al.p73expressionisassociated with the cellular radiosensitivity in cervical cancer after radiotherapy[J].Clin Cancer Res,2004,10(10):3309-3316.
  • 3Wu L,Zhu H,Nie L,et al.A link between p73 transcriptional activity and p73 degradation[J].Oncogene,2004,23 (22):4032-4036.
  • 4Han S,Semba S,Abe T,et al.Infrequent somatic mutations of the p73 gene in various human cancers[J].Eur J Surg Onocl,1999,25(2):194-198.
  • 5Matyakhina L,Pack S,Kirschner L S,et al.Chromosome 2(2p16) abnormalities in Carney complex tumours[J].Medical Genetics,2003,40(4):268-274.
  • 6宫向前,寿楠海,张永生,王启堂.p16基因在乳腺癌中的表达及临床意义[J].肿瘤防治杂志,2002,9(2):142-143. 被引量:1
  • 7Cutress R I,Townsend P A,Brimmell M,et al.BAG-1 expression and function in human cancer[J].Er J Cancer,2002,7(8):834-839.
  • 8Tang S C.BAG-1,an anti-apoptotic tumour marker[J].Iubmb Life,2002,53(2):99-105.
  • 9Sjostrom J,Blomqvist C,von-Boguslawski K,et al.The Predictive value of bcl-2,bax,bcl-xL,BAG-1,fas,and fasL for chemotherapy response in advanced breast cancer[J].Clin Cancer Res,2002,8(3):811-816.
  • 10师建国,林雨冬,闫庆国,王文勇,王文亮.乳腺癌组织芯片中凋亡相关基因BAG-1的表达及其意义[J].中国普通外科杂志,2004,13(5):369-371. 被引量:4

二级参考文献17

  • 1[1]Geradts J,Kratzke RA, Niehans GA,et al. Immunohistochemical detec-tion of the cyclin-dependent kinase inhibitor2/multiple tumor supprssor genel (CDKN2/MTS1) product p161NK4A in archival human solid tumors: correlation with retinoblastoma protein expression [J ]. Cancer Res, 1995,55(24) :6006 - 6011.
  • 2[2]Traris J.Closing in on melanoma susceptibility gene(s)[J].Science,1992,258(5085): 1080 - 1081.
  • 3[3]Serrano M,Hannon GJ,Beach D,et al.A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4[J ]. Nature,1993,366(6456) :704 - 707.
  • 4[4]Fueyo J, Gomez Manzano C, Yung WK, et al. Adenovirus - mediated pl6/CDKN2 gene tranfer induces growth arrest and modifies the trans-formed phenotype of glioma cells[J ]. Oncogene, 1996, 12( 11 ): 103 -110.
  • 5[5]Quesnel B,Preudhomme C,lepelley P,et al.Transfer of p161NK4/CDKN2 gene in leukemia cell lines inhibits cell proliferation[J]. Br J Haematol, 1996,95(12) :291 - 298.
  • 6Takayama S, Sato T, Krajewski S, e t a l. Cloning and functional analysis of BAG- 1: Anovel bc1-2 - binding protein with anti - cell death activity[J]. Ce11,1995,80(2) :279 -284.
  • 7Cutress RI, Townsend PA, Brimmell M, et al. BAG-1 expression and function in human cancer [ J ] . Br J Cancer, 2002 , 87(8) :834 -839.
  • 8Tang SC. BAG - 1 , an anti - apoptotic tumour marker [ J ]. IUBMB Life ,2002,53(2) :99 - 105.
  • 9Kononen J , Bubentorf L, Kallioniemi A , e t a l. Tissue Microarrays for high-throughput molecular profiling of tumour specimens [J] ,nat med,1998,4(7) :844 -847.
  • 10Sjostrom J, Blomqvist C, yon Boguslawski K, e t a l. The predictive value of bcl-2, bax, bcl-xL, BAG-1 , fas, and fasL for chemotherapy response in advanced breast cancer [ J ]. Clin Cancer Res, 2002,8(3) :811 -816.

共引文献18

同被引文献38

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部